SOS2 IS A TRACTABLE THERAPEUTIC TARGET TO LIMIT THERAPEUTIC RESISTANCE IN NON-SMALL CELL LUNG CANCER

The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc.

Investigators